[go: up one dir, main page]

DE60330185D1 - Quantifizierung des carnitinspiegels bei dialyse-patienten - Google Patents

Quantifizierung des carnitinspiegels bei dialyse-patienten

Info

Publication number
DE60330185D1
DE60330185D1 DE60330185T DE60330185T DE60330185D1 DE 60330185 D1 DE60330185 D1 DE 60330185D1 DE 60330185 T DE60330185 T DE 60330185T DE 60330185 T DE60330185 T DE 60330185T DE 60330185 D1 DE60330185 D1 DE 60330185D1
Authority
DE
Germany
Prior art keywords
carnitine
deficiency
methods
diagnosing
quantifying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60330185T
Other languages
English (en)
Inventor
Donald H Chace
Gianfranco Fornasini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leadiant Biosciences Inc
Original Assignee
Sigma-Tau Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Pharmaceuticals Inc filed Critical Sigma-Tau Pharmaceuticals Inc
Application granted granted Critical
Publication of DE60330185D1 publication Critical patent/DE60330185D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/02Nutritional disorders
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/17Nitrogen containing
    • Y10T436/173845Amine and quaternary ammonium
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/24Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
DE60330185T 2002-09-23 2003-09-23 Quantifizierung des carnitinspiegels bei dialyse-patienten Expired - Lifetime DE60330185D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/252,115 US7011977B2 (en) 1999-01-30 2002-09-23 Quantification of carnitine levels in dialysis patients
PCT/US2003/029821 WO2004026114A2 (en) 2002-09-23 2003-09-23 Quantification of carnitine levels in dialysis patients

Publications (1)

Publication Number Publication Date
DE60330185D1 true DE60330185D1 (de) 2009-12-31

Family

ID=32029013

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60330185T Expired - Lifetime DE60330185D1 (de) 2002-09-23 2003-09-23 Quantifizierung des carnitinspiegels bei dialyse-patienten

Country Status (11)

Country Link
US (1) US7011977B2 (de)
EP (1) EP1587406B1 (de)
AT (1) ATE449344T1 (de)
AU (1) AU2003278872A1 (de)
CY (1) CY1110607T1 (de)
DE (1) DE60330185D1 (de)
DK (1) DK1587406T3 (de)
ES (1) ES2336787T3 (de)
PT (1) PT1587406E (de)
SI (1) SI1587406T1 (de)
WO (1) WO2004026114A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297545B2 (en) * 1999-01-30 2007-11-20 Pediatrix Screening, Inc. Clinical method for the genetic screening of newborns using tandem mass spectrometry and internal standards therefor
US7333894B2 (en) * 2002-01-31 2008-02-19 Sigma-Tau Pharmaceuticals, Inc. Methods for the diagnosis of hemodialysis patients and utilization of such methods to improve the administration of intravenous levocarnitine treatments to hemodialysis patients
WO2006098192A1 (ja) * 2005-03-16 2006-09-21 Ajinomoto Co., Inc. 生体状態評価装置、生体状態評価方法、生体状態評価システム、生体状態評価プログラム、評価関数作成装置、評価関数作成方法、評価関数作成プログラムおよび記録媒体
WO2016013115A1 (ja) * 2014-07-25 2016-01-28 株式会社 リージャー 希釈生体試料成分の分析方法
GB201916046D0 (en) * 2019-11-04 2019-12-18 Amazentis Sa Diagnostic method

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252489A (en) * 1989-01-17 1993-10-12 Macri James N Down syndrome screening method utilizing dried blood samples
US5316917A (en) * 1992-11-04 1994-05-31 Duke University Automated analysis of free l-carnitine and total short-chain acylcarnitine
US6455321B1 (en) * 1999-01-30 2002-09-24 Neo Gen Screening, Inc. Method for interpreting tandem mass spectrometry data for clinical diagnosis
US6258605B1 (en) 1999-03-26 2001-07-10 Neo Gen Screening, Inc. Clinical method for the genetic screening of newborns using tandem mass spectrometry
IT1306178B1 (it) * 1999-07-27 2001-05-30 Sigma Tau Ind Farmaceuti Uso della l-carnitina e dei suoi alcanoil derivati per la preparazionedi un medicamento utile nel trattamento del paziente affetto da
IT1306179B1 (it) * 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
US6335369B1 (en) * 2000-01-19 2002-01-01 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Treating chronic uremic patients undergoing periodical dialysis
US6429230B1 (en) * 2000-01-19 2002-08-06 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Treating chronic uremic patients undergoing periodical dialysis

Also Published As

Publication number Publication date
AU2003278872A8 (en) 2004-04-08
AU2003278872A1 (en) 2004-04-08
PT1587406E (pt) 2010-02-23
EP1587406A4 (de) 2007-01-03
SI1587406T1 (sl) 2010-03-31
ATE449344T1 (de) 2009-12-15
US7011977B2 (en) 2006-03-14
ES2336787T3 (es) 2010-04-16
EP1587406B1 (de) 2009-11-18
CY1110607T1 (el) 2015-04-29
DK1587406T3 (da) 2010-03-15
WO2004026114A2 (en) 2004-04-01
WO2004026114A3 (en) 2004-08-19
EP1587406A2 (de) 2005-10-26
US20030129762A1 (en) 2003-07-10

Similar Documents

Publication Publication Date Title
AU2003213594A1 (en) Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples
NO20053976L (no) Online kilderekonstruksjon for EEG/MEG og ECG/MCG.
BR112017021305A2 (pt) dispositivo de teste de fluxo lateral, e, método e kit para detecção quantitativa de um analito em uma amostra de saliva
WO2008014132A3 (en) Combination analyte measurement device and method of use
WO2007126444A3 (en) Analyte monitoring
JP2007502412A5 (de)
TW200736606A (en) Gated voltammetry
CY1110607T1 (el) Ποσοτικοποιηση επιπεδων καρνιτινης σε ασθενεις που υποβαλλονται σε αιμοκαθαρση
WO2008097773A8 (en) Methods and devices for diagnosis of appendicitis
WO2008114377A1 (ja) 運動状態検出装置、運動状態検出プログラム、運動状態検出方法
ES2349107T8 (es) Método analítico e instrumento.
EP1310797A3 (de) Verfahren zur Kontrolle einer nervenschützenden Behandlung
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드n―메틸트랜스퍼라아제의 용도
DK2185939T3 (da) Engangsanalyseudstyr med mikroprocessor
ATE514948T1 (de) In vitro verfahren zur diagnose von neurodegenerativen erkrankungen
WO2008145701A9 (en) Method for predicting the outcome of a critically ill patient
WO2007015113A3 (en) New protein isoforms of the pif-family and uses thereof
DE502005010516D1 (de) Analytisches System und Verfahren zu dessen Betrieb
DE602006015702D1 (de) Unterscheidung zwischen baktiereller meningitis und viraler meningitis
WO2005039487A3 (en) Method for early detection of ovarian cancer
WO2007081777A3 (en) METHODS FOR ACCURATELY MEASURING FREE IgE IN THE PRESENCE OF AN ANTI-IgE THERAPEUTIC
JP2003207495A5 (de)
WO2008093263A3 (en) Breath analysis device
WO2005072341A3 (en) Detection of mesothelin-/megakaryocyte potentiating factor-related peptides in peritoneal fluid for assessment of the peritoneum and the peritoneal cavity
GB0225885D0 (en) Quantifying exposure to stress

Legal Events

Date Code Title Description
8364 No opposition during term of opposition